scispace - formally typeset
D

Dong Jae Kim

Researcher at Daegu Gyeongbuk Institute of Science and Technology

Publications -  86
Citations -  2224

Dong Jae Kim is an academic researcher from Daegu Gyeongbuk Institute of Science and Technology. The author has contributed to research in topics: Immune system & Zebrafish. The author has an hindex of 22, co-authored 86 publications receiving 1906 citations. Previous affiliations of Dong Jae Kim include University of Michigan & Korea Research Institute of Bioscience and Biotechnology.

Papers
More filters
Journal ArticleDOI

Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice.

TL;DR: The amount of conjugated linoleic acid produced by Lactobacillus rhamnosus PL60 was enough to produce an anti-obesity effect on diet-induced obese mice, and the size of epididymal adipocytes was not reduced, and apoptotic signals and UCP-2 mRNA levels increased in adipose tissue.
Journal ArticleDOI

Immune cells in the female reproductive tract.

TL;DR: It is evident that NK cells and regulatory T (Treg) cells are extremely important in decidual angiogenesis, trophoblast migration, and immune tolerance during pregnancy.
Journal ArticleDOI

The Cag pathogenicity island and interaction between TLR2/NOD2 and NLRP3 regulate IL-1β production in Helicobacter pylori infected dendritic cells.

TL;DR: In this article, the authors identify bacterial cag pathogenicity island and the cooperative interaction among host innate receptors TLR2, NOD2, and NLRP3 as important regulators of IL-1β production in H. pylori infected DCs.
Journal ArticleDOI

Nod2-mediated recognition of the microbiota is critical for mucosal adjuvant activity of cholera toxin

TL;DR: It is shown that the microbiota is critical for inducing antigen-specific IgG production after intranasal immunization and a role for the microbiota and the intracellular receptor Nod2 in promoting the mucosal adjuvant activity of CT is shown.
Journal ArticleDOI

Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43.

TL;DR: Polyclonal and monoclonal antibodies are raised using a recombinant form of the SARS virus nucleocapsid protein and cross-reactivity of these anti-SARS Abs against human coronavirus (HCoV) 229E and HCoV OC43 was determined by Western blotting.